How long can you live with liver metastasis? Generally about a year

The liver is an organ where various malignant tumors are prone to metastasis and is one of the most common sites for metastatic cancer. Tumors can metastasize to the liver through the blood or lymphatic pathways. Common liver metastases are mostly from the digestive tract, lungs, pancreas, kidneys, and breasts. Generally, the primary cancer symptoms appear first, and the metastatic cancer symptoms appear in the late stage.

Since the mesenteric blood vessels drain into the portal vein, the chance of colorectal cancer metastases to the liver is relatively high. 10% to 20% of patients have liver metastases during the first surgery, and about 40% to 50% of patients will have liver metastases about 2 years after surgery. The liver metastasis rate of colorectal cancer patients at autopsy can be as high as 36% to 81%.
How long can a patient with liver metastasis live? For example, if liver metastasis is not treated, the median survival period is 4 to 7 months, and generally does not exceed 1 year. In recent years, it is believed that surgical resection of liver metastases can achieve better results. If there are single or multiple liver metastases limited to one lobe at the time of surgery, they can be removed at the same time. If liver metastases occur after surgery, as long as the primary lesion is still under control and liver function is normal, surgical resection can also be considered. It is reported that the 5-year survival rate after resection of isolated liver metastases is about 40%, 15% for single-lobe multifocal lesions, and the effect is poor for extensive metastases in both lobes, with a 1-year survival of about 6% and a 5-year survival of only 1%. For patients who cannot undergo surgical resection, hepatic artery embolization + chemotherapy can be considered. Commonly used perfusion drugs include DDP, MMC, 5-FU, etc. Commonly used auxiliary drugs include ginsenoside Rh2, a ginseng essence extract with a content of about 16%.